A Global Leader in Digital Diagnostics

  • Our Mission

    Build next generation computational technology that unlocks insights from each sample for doctors to optimize patient outcomes.

  • Our Vision

    Create a world where patients get deep, comprehensive insights into their biology, so diagnoses translate into effective, personalized treatments.

Our Story

With a potential 60 percent increase in the number of cancer cases globally in the next two decades and a decrease in the number of pathologists relative to this diagnostic demand, the need to expedite advancements in pathology is pressing. This issue is further exacerbated by the fact that pathology — despite being the foundation of diagnosis — has yet to become digital.

Led by a team of experts in pathology, machine learning, healthcare, and business, Paige strives to make it possible to not only provide additional information from digital slides to help pathologists perform their diagnostic work efficiently and accurately, but also to go beyond this traditional work to extract new diagnostic information from pathology slides and patient samples that have the potential to support informed treatment pathways for patients. Paige technology is also helping life sciences companies evaluate and design personalized treatments for patients. 

Our Team

A Top-Notch Team Driven To Reimagine How Patients Are Diagnosed and Treated

Paige is being built by an outstanding group of experts in pathology, machine learning, healthcare, and business growth that come from leading companies and institutions like Arterys, Foundation Medicine, HeartFlow, Memorial Sloan Kettering Cancer Center, Merck, NASA, and NVIDIA.


  • Andy Moye, PhD, MBA Chief Executive Officer
  • Jill Stefanelli, PhD President & Chief Business Officer
  • David S. Klimstra, MD Founder, Chief Medical Officer
  • Thomas Fuchs, Dr.Sc. Founder, Chief Scientist
  • Juan Retamero, MD Medical Director
  • Razik Yousfi Vice President of Engineering
  • Jillian Sue Director of Product
  • Chris Kanan, PhD Director, AI Scientist
  • Brandon Rothrock, PhD Director, AI Scientist

Advisory Board

  • Jorge Reis-Filho, MD, PhD, FRCPath

    Principal of Biomarker Development, Paige

    Chief, Experimental Pathology Service, Memorial Sloan Kettering Cancer Center

  • David Rimm, MD, PhD Professor of Pathology, Yale University School of Medicine
  • Marc Ladanyi, MD Chief, Molecular Diagnostics Service, Memorial Sloan Kettering Cancer Center
  • John Iafrate, MD, PhD

    Professor of Pathology,​ Harvard Medical School

    Vice Chair for Academic Affairs, Massachusetts General Hospital​ Pathology Department


  • Kenan Turnacioglu, PhD

    Board Chairman, Paige

    General Partner, Catalio Capital Management

  • Jim Breyer

    Board Member, Paige

    Founder and CEO, Breyer Capital

  • Robert Galvin, MD, MBA

    Board Member, Paige

    CEO, Equity Healthcare

    Operating Partner, Blackstone

  • Thomas J. Kelly, MD, PhD

    Board Member, Paige

    Benno S. Schmidt Chair of Cancer Research; Member, Memorial Sloan Kettering Cancer Center; Professor, Weill Graduate School of Biomedical Sciences, Cornell University

  • Eli Casdin

    Board Member, Paige

    Founder, Casdin Capital

  • Asish K. Xavier

    Board Member, Paige

    Vice President, Venture Investments Johnson & Johnson Innovation - JJDC, Inc.

  • Jefrey C. Lightcap

    Board Member, Paige

    Senior Managing Director, Healthcare Venture Partners, LLC

  • Ali Satvat

    Board Member, Paige

    Partner, Co-Head of Health Care and Global Head of Health Care Strategic Growth, KKR




11 Times Square, Fl 37

New York, NY, 10036

In the heart of midtown Manhattan.